
Glyset Mix Penset100 IU/ml
Incepta Pharmaceuticals Ltd.
Insulin Aspart is a rapid-acting human insulin analog indicated for the treatment of diabetes mellitus to improve glycemic control.
Insulin Aspart is a rapid-acting human insulin analog indicated for the treatment of diabetes mellitus to improve glycemic control.
Insulin Aspart is not a substitute for basal insulin and does not treat diabetic ketoacidosis on its own; it is used as part of a comprehensive diabetes management plan under medical supervision.
Dosage of Insulin Aspart is individualized based on blood glucose monitoring, metabolic needs, body weight, lifestyle, and the type of diabetes being treated. It must be determined and adjusted by a physician.
| Population | Typical guidance |
|---|---|
| Adults | Given as part of a multiple daily injection regimen with a longer-acting basal insulin, or by continuous subcutaneous infusion via pump. Mealtime dose is typically individualized (often started around 50–70% of total daily insulin requirement divided between meals) and titrated by the physician based on response. |
| Pediatric patients | Used in children with type 1 diabetes as part of a basal-bolus regimen; dose is individualized by a pediatric endocrinologist/physician based on age, weight, and glycemic targets. |
Used alone or added to oral antidiabetic agents or basal insulin for mealtime glucose control; starting dose and titration are individualized by the treating physician based on blood glucose monitoring.
Subcutaneous injections of Insulin Aspart are generally given shortly before the start of a meal (5–10 minutes prior); certain ultra-rapid formulations may be dosed at the start of a meal or, when needed, within 20 minutes after starting a meal, per the specific product labeling and physician instruction.
Insulin requirements may be reduced in patients with renal or hepatic impairment; more frequent blood glucose monitoring and dose adjustment of Insulin Aspart may be required in these patients, under physician supervision.
The most common and clinically important adverse effect of Insulin Aspart is hypoglycemia, which can be serious and, in severe cases, life-threatening. Symptoms include sweating, tremor, palpitations, confusion, blurred vision, and, if untreated, seizures or loss of consciousness.
Other reported side effects include:
Insulin Aspart is contraindicated in:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.